Physician profile
Marian Rewers
NPI 1083628309
$178,117.93
in general payments reported to CMS, 2019-2025
7 companies · $68K in 2025
The $68K reported for 2025 was more than what 98% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.16 · 2021: $8,100 · 2022: $16K · 2023: $3,993 · 2024: $82K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $90K · Travel and Lodging: $50K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $89,604.24 |
| Travel and Lodging | $49,631.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,121.85 |
| Food and Beverage | $576.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $117,539.53 | 2023-2025 | |
| Sanofi US Services INC. | $25,989.64 | 2025 | |
| Janssen Research & Development, LLC | $23,900.00 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $10,230.24 | 2025 | |
| Medtronic, INC. | $364.36 | 2022-2023 | Minimed 780g |
| Medtronic Minimed, INC. | $94.16 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marian Rewers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.